Features | Hepatocellular carcinoma | ||||
---|---|---|---|---|---|
Gender | Male | ||||
Age (years) | 39 | 40 | 60 | 77 | 53 |
BCLC | B | B | C | A | A |
T stage | 2 | 3 | 2 | 1 | 1 |
N stage | 0 | 1 | 1 | 0 | 0 |
M stage | 0 | 0 | 0 | 0 | 0 |
Tumor size | ≤5 cm | ≤5 cm | ≤5 cm | ≤5 cm | ≤5 cm |
HBV DNA (IU/ml) | 1.93×106 | 3.25×103 | <5.00×102 | <5.00×102 | <5.00×102 |
Hepatitis B surface Ag | Positive | Positive | Positive | Positive | Positive |
Serum AFP (ng/ml) | 3198.75 | 6316.99 | 60.22 | 33.04 | 1434.1 |
PIVKA (ug/L) | 1520.7 | 7010.49 | 687.56 | 222.55 | 552.24 |
BCLC: Barcelona clinic liver cancer, T stage: the size and extent of the main tumor, N stage: the number of nearby lymph nodes that have cancer, M stage: whether the cancer has metastasized, HBV: hepatitis B virus, AFP: alpha-fetoprotein, PIVKA: protein induced by vitamin K absence